These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29563168)
1. Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis. Coghlan JG; Wolf M; Distler O; Denton CP; Doelberg M; Harutyunova S; Marra AM; Benjamin N; Fischer C; Grünig E Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29563168 [TBL] [Abstract][Full Text] [Related]
2. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis. Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357 [TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Bae S; Saggar R; Bolster MB; Chung L; Csuka ME; Derk C; Domsic R; Fischer A; Frech T; Goldberg A; Hinchcliff M; Hsu V; Hummers L; Schiopu E; Mayes MD; McLaughlin V; Molitor J; Naz N; Furst DE; Maranian P; Steen V; Khanna D Ann Rheum Dis; 2012 Aug; 71(8):1335-42. PubMed ID: 22307943 [TBL] [Abstract][Full Text] [Related]
4. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Schreiber BE; Valerio CJ; Keir GJ; Handler C; Wells AU; Denton CP; Coghlan JG Arthritis Rheum; 2011 Nov; 63(11):3531-9. PubMed ID: 21769839 [TBL] [Abstract][Full Text] [Related]
5. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Colalillo A; Hachulla E; Pellicano C; Smith V; Bergmann C; Riemekasten G; Zanatta E; Henes J; Launay D; Marcoccia A; Gheorghiu AM; Truchetet ME; Iannone F; Simeón Aznar CP; Oliveira S; Vonk M; Del Galdo F; Rosato E; Chest; 2024 Oct; 166(4):837-844. PubMed ID: 38849072 [TBL] [Abstract][Full Text] [Related]
6. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography. Choi JH; Joo SJ; Kim J Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839 [TBL] [Abstract][Full Text] [Related]
7. Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis. Yoneda K; Takahashi S; Nakayama K; Iwahashi M; Emoto N; Kumagai S Int J Rheum Dis; 2023 Mar; 26(3):493-500. PubMed ID: 36737419 [TBL] [Abstract][Full Text] [Related]
8. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up. Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685 [TBL] [Abstract][Full Text] [Related]
10. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505 [TBL] [Abstract][Full Text] [Related]
11. Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. Hsu VM; Chung L; Hummers LK; Wigley F; Simms R; Bolster M; Silver R; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Alkassab F; Steen VD Semin Arthritis Rheum; 2014 Aug; 44(1):55-62. PubMed ID: 24709277 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR; Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension. Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population. Hinchcliff M; Fischer A; Schiopu E; Steen VD; J Rheumatol; 2011 Oct; 38(10):2172-9. PubMed ID: 21844142 [TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. Hsu VM; Chung L; Hummers LK; Shah A; Simms R; Bolster M; Hant FN; Silver RM; Fischer A; Hinchcliff ME; Varga J; Goldberg AZ; Derk CT; Schiopu E; Khanna D; Shapiro LS; Domsic RT; Medsger T; Mayes MD; Furst D; Csuka ME; Molitor JA; Saketkoo LA; Salazar CR; Steen VD J Rheumatol; 2019 Feb; 46(2):176-183. PubMed ID: 30275260 [TBL] [Abstract][Full Text] [Related]
17. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M; Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. Iudici M; Codullo V; Giuggioli D; Riccieri V; Cuomo G; Breda S; Manfredi A; Iannace N; D'Alto M; Ghio S; Rossi R; Vizza CD; Caporali R; Valesini G; Ferri C; Valentini G Clin Exp Rheumatol; 2013; 31(2 Suppl 76):31-6. PubMed ID: 23910607 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956 [TBL] [Abstract][Full Text] [Related]
20. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]